Jilin Maifeng Rabies Vaccine (Vero Cell)

Jilin Maifeng Rabies Vaccine (Vero Cell) is an inactivated viral vaccine produced by Jilin Maifeng Biotech Pharmaceutical Co., Ltd. for the prevention of rabies in humans. The vaccine is manufactured using Vero cell culture technology and is administered via intramuscular injection, typically following the Essen (1-1-1-1-1) or Zagreb (2-1-1) immunization schedules. It is designed to induce active immunity by stimulating the production of neutralizing antibodies against the rabies virus. In the context of clinical trials in China, such as those sponsored by the Jiangsu Province Centers for Disease Control and Prevention, it is commonly employed as a standard-of-care comparator to evaluate the safety and immunogenicity of novel rabies vaccine candidates.

Brand names

Jilin Maifeng

Other names

Rabies Vaccine (Vero Cell) for Human Use (Jilin Maifeng)Jilin Maifeng-Jiangsu Province Centers for Disease Control and Prevention-Rabies